Clinical Trial Detail

NCT ID NCT02408042
Title Study of Pembrolizumab With Chemotherapy in Patients With Advanced Lymphoma (PembroHeme)
Recruitment Withdrawn
Gender both
Phase Phase Ib/II
Variant Requirements no
Sponsors Western Regional Medical Center
Indications

diffuse large B-cell lymphoma

non-Hodgkin lymphoma

Hodgkin's lymphoma

Therapies

Rituximab

Carboplatin + Etoposide + Ifosfamide

Pembrolizumab

Brentuximab vedotin

Age Groups: adult

No variant requirements are available.